These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32417769)

  • 1. A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices.
    Erhabor O; Azachi WB; Tosan E
    Hum Antibodies; 2020; 28(3):245-252. PubMed ID: 32417769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies.
    Osaro E; Charles AT
    Int J Womens Health; 2010 Dec; 2():429-37. PubMed ID: 21270966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
    Ayenew AA
    Matern Health Neonatol Perinatol; 2021 Feb; 7(1):8. PubMed ID: 33531050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
    Sahoo D; Anuragaa S; Abhishekh B
    Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Rhesus C and D Alloantibodies among Rhesus-Negative Women of Child Bearing Age at a Tertiary Hospital in South-West Nigeria.
    Otomewo L; John-Olabode S; Okunade K; Olorunfemi G; Ajie I
    Niger J Clin Pract; 2020 Dec; 23(12):1759-1766. PubMed ID: 33355832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss.
    Mohd Nazri H; Noor Haslina MN; Shafini MY; Noor Shaidatul Akmal AR; Rapiaah M; Wan Zaidah A
    Malays J Pathol; 2017 Apr; 39(1):73-76. PubMed ID: 28413208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of alloantibodies associated with haemolytic disease of the fetus and newborn in pregnant women at the Ekiti State University Teaching Hospital, Ado-Ekiti, Southwest Nigeria.
    Olayanju AO; Chris NI; Emmanuel AE; Oyetunde AB; Adebisi KY; Okolo CS
    Afr J Reprod Health; 2023 Jun; 27(6s):70-78. PubMed ID: 37694704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe foetal anaemia caused by undetected alloimmunisation in a RhD-positive pregnant woman].
    Krabek R; Bergholt T; Johansen M; Nørgaard LN; Heiring C; Dziegiel MH; Ekelund CK
    Ugeskr Laeger; 2021 Aug; 183(32):. PubMed ID: 34378528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
    Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
    Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohort.
    Zwiers C; Slootweg YM; Koelewijn JM; Ligthart PC; van der Bom JG; van Kamp IL; Lopriore E; van der Schoot CE; Oepkes D; de Haas M
    Vox Sang; 2024 Aug; 119(8):859-866. PubMed ID: 38772910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
    Sidhu M; Bala R; Akhtar N; Sawhney V
    Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy.
    Chatziantoniou V; Heeney N; Maggs T; Rozette C; Fountain C; Watts T; Harrison C; Pasupathy D; Sankaran S; Kyle P; Robinson S
    Transfus Med; 2017 Aug; 27(4):275-285. PubMed ID: 28608631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
    Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
    Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
    Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
    Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management.
    Li S; He Z; Luo Y; Ji Y; Luo G; Fang Q; Gao Y
    BMC Pregnancy Childbirth; 2020 Sep; 20(1):539. PubMed ID: 32938441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.